Table 3. Univariable association between analysed data points and survival outcome measures.
p values have been rounded to two decimal places. PS: performance status, ANOVA: analysis of variance, MGMT: O(6)-methylguanine-DNA methyltransferase, IDH: isocitrate dehydrogenase.
| Variable | Survival (days) | Mortality (15 months) | ||
| ANOVA (F) | p value | Chi Sq (χ2) | p value | |
| Sex | 0.70 | 0.79 | 0.42 | 0.75 |
| Radiotherapy | 66.91 | < 0.01 | 123.01 | < 0.01 |
| Chemotherapy | 42.37 | < 0.01 | 119.91 | < 0.01 |
| Treatment group | 3.88 | 0.05 | 1.69 | 0.51 |
| MGMT methylation | 3.98 | 0.05 | 6.38 | < 0.01 |
| IDH mutation | 2.48 | 0.12 | 15.37 | 0.06 |
| Anatomical location | 9.98 | < 0.01 | 15.29 | 0.06 |
| Pre-operative PS | 4.45 | 0.04 | 12.45 | 0.09 |
| Post-operative PS | 12.47 | < 0.01 | 13.94 | 0.07 |
| Change in PS | 4.33 | 0.04 | 9.79 | 0.13 |
| New deficit | 1.99 | 0.16 | 0.45 | 0.74 |
| > 90% resection | 15.80 | < 0.01 | 0.01 | 0.01 |